Over the past two years, Thales in the UK has embarked on a remarkable journey with Asthma and Lung UK, united by a shared commitment to making a difference in the lives of those affected by lung conditions. Thanks to the incredible efforts of our employees, we raised over £226,000, a testament to our collective spirit and dedication to community welfare.

This partnership has not only been about fundraising but also about igniting hope and driving research forward. Our contribution has directly supported pioneering research aimed at improving asthma diagnosis in children, ensuring quicker and more accurate treatments for our youngest and most vulnerable.

Alex Cresswell, CEO for Thales in the UK, said,

Seeing our team come together for Asthma and Lung UK highlights their genuine passion and commitment to support this vital cause. This initiative reflects our collective drive for meaningful innovation and community support. The upcoming 'Thales Community Investment Fund' will allow us to extend this spirit of generosity, impacting even more lives positively. I am deeply grateful for everyone's efforts, which showcase the true essence of our Thales community.

As we close this chapter with Asthma and Lung UK, we extend our deepest gratitude to everyone who played a part in this journey. Special recognition goes to our charity champions, fundraisers, and the Thales Management Board, whose enthusiasm and creativity have been nothing short of inspirational.

Looking ahead, Thales in the UK is excited to introduce the 'Thales Community Investment Fund,' a new initiative to broaden our impact across various local charities and community groups. This fund represents our ongoing commitment to being a force for good, reflecting our core values of solidarity and innovation.

We thank each one of you for your unwavering support and invite you to join us in this next phase of our community engagement journey. Together, we can continue to make a significant difference in the lives of many.